{
    "clinical_study": {
        "@rank": "124233", 
        "arm_group": [
            {
                "arm_group_label": "Advil with Ultherapy", 
                "arm_group_type": "Active Comparator", 
                "description": "Subjects randomized to this study arm will receive Advil prior to an Ulthera System Treatment."
            }, 
            {
                "arm_group_label": "Lortab with Ultherapy", 
                "arm_group_type": "Active Comparator", 
                "description": "Subjects randomized to this study arm will receive Lortab prior to an Ulthera System Treatment."
            }
        ], 
        "brief_summary": {
            "textblock": "This study will compare the effectiveness of two pain medications for reducing discomfort\n      during an Ultherapy treatment."
        }, 
        "brief_title": "Feasibility Study: Compare the Effectiveness Between Two Pain Medications When Used Prior to Ultherapy\u2122 Treatments", 
        "completion_date": {
            "#text": "February 2012", 
            "@type": "Actual"
        }, 
        "condition": "Skin Laxity", 
        "condition_browse": {
            "mesh_term": "Cutis Laxa"
        }, 
        "detailed_description": {
            "textblock": "This trial is a prospective, single-site, double-blinded, randomized trial.  All study\n      subjects will receive a full face and neck Ultherapy treatment.  Subjects will be randomized\n      to receive one of two pain medications prior to treatment.  Each subject will be asked to\n      rate the level of discomfort during the Ultherapy treatment.  All study subjects will be\n      followed for 90 days following treatment."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female, aged 30 to 65 years\n\n          -  Subject in good health\n\n          -  Skin laxity on the upper and lower face and neck\n\n          -  Understands and accepts the obligation not to undergo any other procedures in the\n             areas to be treated through the followup period\n\n        Exclusion Criteria:\n\n          -  Known sensitivity to ibuprofen, acetaminophen, or opiates\n\n          -  Presence of an active systemic or local skin disease that may affect wound healing\n\n          -  Severe solar elastosis\n\n          -  Excessive subcutaneous fat in the face and neck\n\n          -  Excessive skin laxity on the face and neck\n\n          -  Significant scarring in areas to be treated\n\n          -  Significant open facial wounds or lesions\n\n          -  Severe or cystic acne on the face\n\n          -  Presence of a metal stent or implant in the facial area to be treated"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "30 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 15, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01708473", 
            "org_study_id": "ULT-123"
        }, 
        "intervention": [
            {
                "arm_group_label": "Advil with Ultherapy", 
                "description": "One (1) tablet 800 mg Advil one hour prior to treatment.", 
                "intervention_name": "Advil", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Lortab with Ultherapy", 
                "description": "One (1) tablet 10/500 mg of Lortab one hour prior to treatment.", 
                "intervention_name": "Lortab", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Advil with Ultherapy", 
                    "Lortab with Ultherapy"
                ], 
                "description": "Focused ultrasound energy delivered below the surface of the skin", 
                "intervention_name": "Ulthera System Treatment", 
                "intervention_type": "Device", 
                "other_name": [
                    "Ulthera\u00ae System", 
                    "Ultherapy\u2122 Treatment", 
                    "Ulthera, Inc.", 
                    "Ultrasound treatment for skin tightening"
                ]
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Ibuprofen", 
                "Acetaminophen, hydrocodone drug combination"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "June 27, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Rockville", 
                    "country": "United States", 
                    "state": "Maryland", 
                    "zip": "20852"
                }, 
                "name": "Dermatology, Cosmetic & Laser Surgery"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Feasibility Study: Comparison Of Advil\u00ae Vs. Lortab\u00ae For Reducing Discomfort Associated With Ultherapy\u2122 Treatment", 
        "overall_official": {
            "affiliation": "Dermatology, Cosmetic & Laser Surgery", 
            "last_name": "Hema Sundaram, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The validated NRS scale will be used to measure average pain scores reported by subject during treatment.", 
            "measure": "Treatment discomfort", 
            "safety_issue": "No", 
            "time_frame": "During treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01708473"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Improvement in overall lifting and tightening of skin as determined by a masked, qualitative assessment of photographs.", 
            "measure": "Improvement in skin laxity", 
            "safety_issue": "No", 
            "time_frame": "90 days following treatment"
        }, 
        "source": "Ulthera, Inc", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ulthera, Inc", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}